col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


159 Results       Page 1

 [1] 
Elsevier: Biophysical Journal
  original article Date Title Authors   All Authors
1 [GO] 2022―Nov―17 Structural Effects of Spike Protein D614G Mutation in SARS-CoV-2 Hisham M. Dokainish, Yuji Sugita
2 [GO] 2022―Aug―28 Circulating cell clusters aggravate the hemorheological abnormalities in COVID-19 Elahe Javadi, He Li, Ander Dorken Gallastegi, Galit H. Frydman, Safa Jamali, George Em Karniadakis
3 [GO] 2022―May―20 Finite element modeling of alpha-helices and tropocollagen molecules with reference to the spike of SARS-CoV-2 Tomasz Wierzbicki, Yuanli Bai
4 [GO] 2022―Apr―07 Role of spatial patterning of N-protein interactions in SARS-CoV-2 genome packaging Ian Seim, Christine A. Roden, Amy S. Gladfelter
5 [GO] 2022―Apr―02 Modeling insights into SARS-CoV-2 respiratory tract infections prior to immune protection Alexander Chen, Timothy Wessler, Katherine Daftari, Kameryn Hinton, Richard C. Boucher, Raymond Pickles, et al. (+3)
6 [GO] 2022―Feb―11 Developing drugs against essential proteins of SARS-CoV-2 for the treatment of COVID-19 Teena Bajaj
7 [GO] 2022―Feb―11 Predictive mathematical models of the growth of the COVID-19 pandemic Juan Luis Fernández-Martínez, Zulima Fernández-Muñiz, Ana Cernea, Andrzej Kloczkowski
8 [GO] 2022―Feb―11 A year in the life of SARS-CoV-2 Mpro: molecular modeling and analysis of clinically observed Mpro variants from the first year of the COVID-19 pandemic Elizabeth M. Diessner, Gemma R. Takahashi, Thomas J. Cross, Carter T. Butts, Rachel W. Martin
9 [GO] 2022―Feb―11 Catalytic function and substrate specificity of alpha and beta coronavirus papain-like proteases: targeting human NL63, SARS-CoV and SARS-CoV-2 (Covid-19) with designed inhibitors Mackenzie E. Chapman, Courtney M. Daczkowski, Arun K. Ghosh, Andrew D. Mesecar
10 [GO] 2022―Feb―11 Quantitative analysis of hypericin interaction with SARS-CoV 2 and with a model membrane Matteo Mariangeli, Eleonora Uriati, Chantal Usai, Andrea Mussini, Samira Jadavi, Silvia Dante, et al. (+7)
11 [GO] 2022―Feb―11 Structural dynamic changes in the SARS-CoV and SARS-CoV-2 S spike assemblies upon ACE2 activation Chengbo Chen, James B. Munro, Kelly K. Lee
12 [GO] 2022―Feb―11 Structural and dynamical impact of the two-nucleotide difference in sequence between SARS-CoV and SARS-CoV-2 s2m using molecular dynamics Adam H. Kensinger, Kendy A. Pellegrene, Joseph A. Makowski, Caylee L. Cunningham, Caleb J. Frye, Mihaela-Rita Mihailescu, Jeffrey D. Evanseck
13 [GO] 2022―Feb―11 Characterizing the roles of chemo-mechanical couplings in the differential behavior of SARS-CoV-1 and SARS-CoV-2 spike glycoprotein Ugochi H. Isu, Vivek Govind Kumar, Mortaza Derakhshani-Molayousefi, Adithya Polasa, Mahmoud Moradi
14 [GO] 2022―Feb―11 Automated refinement protocol to improve the quality of protein structures deposited in the protein data bank, applied to SARS-Cov-2 Joseph Farrell, Esmael J. Haddadian
15 [GO] 2022―Feb―11 Stem-loop II motif (s2m) structural and dynamical differences between SARS-CoV-2 and b.1.617.2 (Delta) variant Joseph A. Makowski, Adam H. Kensinger, Kendy A. Pellegrene, Caylee Cunningham, Caleb J. Frye, Morgan Shine, et al. (+4)
16 [GO] 2022―Feb―11 The discovery of antivirals and novel targets for SARS-CoV-2 and EV-A71 Christina Haddad, Blanton S. Tolbert, Amanda E. Hargrove, Gary Brewer, Mei-Ling Li
17 [GO] 2022―Feb―11 Structural dynamics of prefusion spike protein of SARS-CoV-2 and its variants Mortaza Derakhshani-Molayousefi, Ugochi Isu, Mahmoud Moradi
18 [GO] 2022―Feb―11 SARS-CoV-2 antibodies specific to the mesa and inner side of spike protein receptor binding domain maintain high affinities for both D614G and b.1.351 variants Kan Li, Richard H.C. Huntwork, Gillian Q. Horn, Elizabeth Feeney, Kathryn M. Hastie, Haoyang Li, et al. (+9)
19 [GO] 2022―Feb―11 Characterization of the S2M G15U mutation associated with the SARS-CoV-2 delta variant Caylee L. Cunningham, Caleb J. Frye, Joshua A. Imperatore, Kendy A. Pellegrene, Adam H. Kensinger, Joseph A. Makowski, et al. (+4)
20 [GO] 2022―Feb―11 Changes in the receptor-binding interface may cause immune evasion by the SARS-CoV-2 delta variant b.1.617.2 Prabin Baral, Nisha Bhattarai, Md Lokman Hossen, Vitalii Stebliankin, Bernard S. Gerstman, Giri Narasimhan, Prem P. Chapagain
21 [GO] 2022―Feb―11 Impact of mutations near the SARS-CoV-2 furin-cleavage site on viral infectivity Kien Nguyen, Srirupa Chakraborty, Pedro D. Manrique, Bette Korber, S. Gnanakaran
22 [GO] 2022―Feb―11 The spike-ACE2 interaction underlying SARS-CoV-2 infection and inhibition is enhanced by intermolecular cross linking Roi Asor, Anna Olerinyova, Manish S. Kushwah, Fabian Soltermann, Lucas Powell Rudden, SnezÌŒana Vasiljevic, et al. (+7)
23 [GO] 2022―Feb―11 Computational investigation of glycosaminoglycan cofactors in SARS-CoV-2 infection dynamics Mia A. Rosenfeld, Fiona L. Kearns, Sang Hoon Kim, Lorenzo Casalino, Micah Papanikolas, Carlos Simmerling, et al. (+2)
24 [GO] 2022―Feb―11 Developing inhibitors of the SARS-CoV-2 main protease Christian Seitz, Vedran Markota, Terra Sztain-Pedone, Morgan Esler, Arad Moghadasi, Samantha Kennelly, et al. (+6)
25 [GO] 2022―Feb―11 Dimethyl sulfoxide (DMSO) affects activity of SARS-CoV-2 main protease Marquise G. Crosby, Gemma R. Takahashi, Rachel W. Martin, Elizabeth Diessner, Brenna Norton-Baker, Carter T. Butts
26 [GO] 2022―Feb―11 Comprehensive virtual screening of 4.8k flavonoids reveals novel insights into the allosteric inhibition of SARS-CoV-2 MPRO Ana Paula Vargas Ruiz, Gabriel Jiménez Avalos, Nicolás E. Delgado, Gustavo Olivos Ramírez, Patricia Sheen, Miguel Quiliano, Mirko Zimic
27 [GO] 2022―Feb―11 Binding and compaction function of structural domains of SARS-CoV-2 nucleocapsid (N) protein on a single stranded nucleic acid substrate Michael Morse, Jana Sefcikova, Ioulia Rouzina, Penny J. Beuning, Mark C. Williams
28 [GO] 2022―Feb―11 Characterizing nucleic acid interactions with the N-Terminal binding domain of the SARS-CoV-2 nucleocapsid protein Jasmine Cubuk, Juan J. Incicco, Melissa D. Stuchell-Brereton, Kathleen B. Hall, Andrea Soranno
29 [GO] 2022―Feb―11 SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA Amanda Jack, Luke Ferro, Michael J. Trnka, Eddie Wehri, Amrut Nadgir, Xammy Nguyenla, et al. (+5)
30 [GO] 2022―Feb―11 Investigating SARS-CoV-2 ORF7a and BST-2 heterodimerization by molecular dynamics simulations Min-Kang Hsieh, Jeffery B. Klauda
31 [GO] 2022―Feb―11 Comparing structural ensembles with DiffNets helps explain the activation mechanism of the SARS-CoV-2 protein NSP16 Michael D. Ward
32 [GO] 2022―Feb―11 Cryo-electron tomography of in vivo reconstituted SARS-CoV-2 replication/transcription organelles Cosmo Z. Buffalo, James H. Hurley
33 [GO] 2022―Feb―11 Single molecule activity assay for SARS-CoV-2 RNA dependent RNA polymerase SangYoon Chung, Yazan Alhadid, Maya Segal, Jookyung Lee, Sergei Borukhov, Shimon Weiss
34 [GO] 2022―Feb―11 Probing remdesivir nucleotide analogue insertion to SARS-CoV-2 RNA dependent RNA polymerase in viral replication Moises E. Romero, Chunhong Long, Daniel La Rocco, Anusha M. Keerthi, Dajun Xu, Jin Yu
35 [GO] 2022―Feb―11 Molecular mechanism for conformational activation of SARS-CoV-2 RNA polymerase by nucleoside triphosphate Wen Ma, J. Andrew McCammon
36 [GO] 2022―Feb―11 SARS-CoV-2 S1 spike protein peptides inhibit alpha 7 nAChRs and are counteracted by a PAM at alpha 7 Joseph Farley, Jonathan B. Anderson
37 [GO] 2022―Feb―11 Decreased interfacial dynamics caused by the N501Y mutation in the SARS-Cov-2 s1 spike:ACE2 complex Wesam S. Ahmed, Angelin M. Philip, Kabir H. Biswas
38 [GO] 2022―Feb―11 A high throughput method for ensemble antibody affinity measurements for SARS-CoV-2 samples Gabrielle Kosoy, Abdul Karim, Phuong Nguyen, Mark Sangster, David Topham, Benjamin Miller
39 [GO] 2022―Feb―11 Probing key interactions between SARS-CoV-2 spike and heparan sulfate Fiona L. Kearns, Mia Rosenfeld, Sang Hoon Kim, Lorenzo Casalino, Micah Papanikolas, Carlos Simmerling, et al. (+2)
40 [GO] 2022―Feb―11 SARS-CoV-2 spike binding to ACE2 is stronger and longer ranged with glycans Yihan Huang, Bradley Harris, Shiaki Minami, Seongwon Jung, Priya Shah, Somen Nandi, et al. (+2)
41 [GO] 2022―Feb―11 Conformational changes in SARS-CoV-2 spike from the delta variant enhances viral transmissibility Varun Venkatakrishnan, Sean Braet, Theresa Buckley, Ganesh S. Anand
42 [GO] 2022―Feb―11 Computational studies of the dynamics of SARS-CoV-2 spike, membrane, and nucleocapsid proteins Mandira Dutta, Gregory A. Voth
43 [GO] 2022―Feb―11 Concerted hinge motions in SARS-CoV-2 spike modulated by glycan-glycan and glycan-lipid interactions Karan Kapoor, Tianle Chen, Emad Tajkhorshid
44 [GO] 2022―Feb―11 Ensemble-based, glycan-dependent epitope analysis of SARS-CoV-2 spike protein Tianle Chen, Karan Kapoor, Emad Tajkhorshid
45 [GO] 2022―Feb―11 Computationally engineered ACE2 decoy binds with nanomolar affinity with the SARS-CoV-2 spike protein Mohammad S. Islam, Brandon Havranek, Erik Procko, Kui Chan
46 [GO] 2022―Feb―11 The roles of glycans in the SARS-CoV-2 spike protein Lorenzo Casalino, Rommie E. Amaro
47 [GO] 2022―Feb―11 Unraveling SARS-CoV-2 spike protein activation pathway reveals unprecedented cryptic pockets Hisham M. Dokainish, Suyong Re, Takaharu Mori, Chigusa Kobayashi, Jaewoon Jung, Yuji Sugita
48 [GO] 2022―Feb―11 Machine learning reveals the critical interactions for SARS-CoV-2 spike protein binding to ACE2 Anna Pavlova, Zijian Zhang, Atanu Acharya, Diane L. Lynch, Yui Tik Pang, Zhongyu Mou, et al. (+3)
49 [GO] 2022―Feb―11 Elucidating the distinct structural features of the SARS-CoV-2 spike protein fusion domain Daniel Birtles
50 [GO] 2022―Feb―11 Host cell membrane capture by the SARS-CoV-2 spike protein fusion intermediate Rui Su, Jin Zeng, Ben O'Shaughnessy
51 [GO] 2022―Feb―11 Impact of SARS-CoV-2 spike protein on α7 nicotinic acetylcholine receptor in cells Tommy S. Tillman, Yan Xu, Pei Tang
52 [GO] 2022―Feb―11 The SARS-CoV-2 spike protein reversibly samples an open-trimer conformation exposing novel epitopes Sophie R. Shoemaker, Shawn M. Costello, Helen T. Hobbs, Annalee W. Nguyen, Ching-Lin Hsieh, Jennifer A. Maynard, et al. (+3)
53 [GO] 2022―Feb―11 Intricacies of the SARS-CoV-2 spike transmembrane trimer organization Elena T. Aliper, Nikolay A. Krylov, Anton A. Polyansky, Roman G. Efremov
54 [GO] 2022―Feb―11 Whole-cell quantitative imaging of structural changes induced by SARS-CoV-2 using soft X-ray tomography Jian-Hua Chen, Valentina Loconte, Mirko Cortese, Axel Ekman, Mark A. Le Gros, Ralf Bartenschlager, et al. (+2)
55 [GO] 2022―Feb―11 AI-Driven prediction of binding trends of SARS-CoV-2 variants from atomistic simulations Sara Capponi, Shangying Wang, Erik Navarro, Simone Bianco
56 [GO] 2022―Feb―11 Differential interactions between human ACE2 and spike RBD of SARS-CoV-2 variants of concern Seonghan Kim, Yi Liu, Zewei Lei, Jeffrey Dicker, Yiwei Cao, Xiaohui Zhang, Wonpil Im
57 [GO] 2022―Feb―11 SARS-Cov-2 variants of concern decelerate the dynamics of spike open conformation as an evolutionary strategy Ziwei Yang, Yang Han, Shilei Ding, Andrés Finzi, Walther Mothes, Maolin Lu
58 [GO] 2022―Feb―11 Structure, dynamics and nanomechanics of wild-type and alpha-variant SARS-CoV-2 virions Dorottya Mudra, Balint Kiss, Zoltán Kis, Bernadett Pályi, Miklós Kellermayer
59 [GO] 2022―Feb―11 Development of a SARS-CoV-2 virus-like particle that performs as a direct cell entry reporter Elena Mekhedov, Matthias Garten, Glen Humphrey, Jennifer D. Petersen, Adriana E. Golding, Hang Waters, Joshua Zimmerberg
60 [GO] 2022―Feb―11 Preparation of SARS-CoV-2 VLP to study viral assembly, egress, and entry Jennifer D. Petersen, Glen Humphrey, Elena Mekhedov, Hang Waters, Joshua Zimmerberg
61 [GO] 2022―Feb―11 Expression of SARS-CoV-2-ORF3a protein induces cardiomyocyte damage Iuliia A. Polina, Yugene Guo, Michael W. Cypress, Elena G. Tolkacheva, Bong Sook Jhun, Jin O-Uchi
62 [GO] 2022―Feb―11 Viral-host RNA-RNA interactions in SARS-CoV-2: study of MIR-760-3p interactions with the genome 3'-untranslated region Caleb J. Frye, Caylee L. Cunningham, Kendy A. Pellegrene, Adam H. Kensinger, Joseph A. Makowski, Jeffrey D. Evanseck, Mihaela-Rita Mihailescu
63 [GO] 2022―Feb―11 A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions Magnus S. Bauer, Sophia Gruber, Adina Hausch, Lukas F. Milles, Thomas Nicolaus, Leonard C. Schendel, et al. (+6)
64 [GO] 2022―Feb―11 Developing lectins as inhibitors of SARS-CoV2 Alex J. Guseman, Linda Murphy, Sham Nambulli, Fatema Bhinderwhala, Paul Duprex, Angela M. Gronenborn
65 [GO] 2021―Dec―18 Importance of Negatively Charged Residues in the Membrane Ordering Activity of SARS-CoV-1 and -2 Fusion Peptides Alex L. Lai, Jack H. Freed
66 [GO] 2021―Dec―07 SARS-Cov-2 Spike binding to ACE2 is stronger and longer ranged due to glycan interaction Yihan Huang, Bradley S. Harris, Shiaki A. Minami, Seongwon Jung, Priya S. Shah, Somen Nandi, et al. (+2)
67 [GO] 2021―Nov―10 Modeling Coronavirus Spike Protein Dynamics: Implications for Immunogenicity and Immune Escape G. Kunkel, M. Madani, S.J. White, P.H. Verardi, A. Tarakanova
68 [GO] 2021―Oct―28 More pandemic reflections H. Jane Dyson
69 [GO] 2021―Jul―31 “Bucket brigade” using lysine residues in RNA-dependent RNA polymerase of SARS-CoV-2 Shoichi Tanimoto, Satoru G. Itoh, Hisashi Okumura
70 [GO] 2021―Jul―14 Biophysicists’ continued outstanding response to COVID-19 Tamar Schlick, Eric J. Sundberg, Susan J. Schroeder, M. Madan Babu
71 [GO] 2021―Jun―30 Role of spatial patterning of N-protein interactions in SARS-CoV-2 genome packaging Ian Seim, Christine A. Roden, Amy S. Gladfelter
72 [GO] 2021―Jun―29 Regulation of epithelial sodium channel activity by SARS-CoV-1 and SARS-CoV-2 proteins Stephen N. Grant, Henry A. Lester
73 [GO] 2021―Jun―29 Transient complexes of the Nsp7, Nsp8 and Nsp12 in SARS-CoV-2 replication transcription complex Mateusz Wilamowski, Michal Hammel, Wellington Leite, Qiu Zhang, Youngchang Kim, Kevin Weiss, et al. (+11)
74 [GO] 2021―Jun―29 Dynamics of the SARS-CoV-2 nucleoprotein N-terminal domain triggers RNA duplex destabilization Ícaro P. Caruso, Karoline Sanches, Andrea T. Da Poian, Anderson S. Pinheiro, Fabio C.L. Almeida
75 [GO] 2021―Jun―02 Physical phenotype of blood cells is altered in COVID-19 Markéta Kubánková, Bettina Hohberger, Jakob Hoffmanns, Julia Fürst, Martin Herrmann, Jochen Guck, Martin Kräter
76 [GO] 2021―Jun―02 Neuropilin-1 Assists SARS-CoV-2 Infection by Stimulating the Separation of Spike Protein Domains S1 and S2 Li Zhen-lu, Buck Matthias
77 [GO] 2021―Jun―02 Enhanced Sampling Protocol to Elucidate Fusion Peptide Opening of SARS-CoV-2 Spike Protein Jacob M. Remington, Kyle T. McKay, Jonathon B. Ferrell, Severin T. Schneebeli, Jianing Li
78 [GO] 2021―May―11 Computational optimization of the SARS-CoV-2 receptor-binding-motif affinity for human ACE2 Savvas Polydorides, Georgios Archontis
79 [GO] 2021―Mar―29 Multivalent binding of the partially disordered SARS-CoV-2 nucleocapsid phosphoprotein dimer to RNA Heather M. Forsythe, Joaquin Rodriguez Galvan, Zhen Yu, Seth Pinckney, Patrick Reardon, Richard B. Cooley, et al. (+4)
80 [GO] 2021―Mar―29 SARS-CoV2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential Neha Vithani, Michael D. Ward, Maxwell I. Zimmerman, Borna Novak, Jonathan H. Borowsky, Sukrit Singh, Gregory R. Bowman
81 [GO] 2021―Mar―09 Exploring dynamics and network analysis of spike glycoprotein of SARS-COV-2 Mahdi Ghorbani, Bernard R. Brooks, Jeffery B. Klauda
82 [GO] 2021―Mar―04 Biophysicists' outstanding response to Covid-19 Tamar Schlick, Eric J. Sundberg, Susan J. Schroeder, M. Madan Babu
83 [GO] 2021―Mar―04 Principles and Practice for SARS-CoV-2 Decontamination of N95 Masks with UV-C Thomas Huber, Olivia Goldman, Alexander E. Epstein, Gianna Stella, Thomas P. Sakmar
84 [GO] 2021―Mar―04 Binding Mode of SARS-CoV2 Fusion Peptide to Human Cellular Membrane Defne Gorgun, Muyun Lihan, Karan Kapoor, Emad Tajkhorshid
85 [GO] 2021―Feb―23 Ca2+-dependent mechanism of membrane insertion and destabilization by the SARS-CoV-2 fusion peptide George Khelashvili, Ambrose Plante, Milka Doktorova, Harel Weinstein
86 [GO] 2021―Feb―18 A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptors A. Sofia F. Oliveira, Amaurys Avila Ibarra, Isabel Bermudez, Lorenzo Casalino, Zied Gaieb, Deborah K. Shoemark, et al. (+4)
87 [GO] 2021―Feb―17 Biomechanical Characterization of SARS-CoV-2 Spike RBD and Human ACE2 Protein-Protein Interaction Wenpeng Cao, Chuqiao Dong, Seonghan Kim, Decheng Hou, Wanbo Tai, Lanying Du, et al. (+2)
88 [GO] 2021―Feb―12 Hydrating the Respiratory Tract: An Alternative Explanation Why Masks Lower Severity of COVID-19 Joseph M. Courtney, Ad Bax
89 [GO] 2021―Feb―12 Vitamin D and Its Derivatives as Promising Drugs Against COVID-19 - A Computational Study Yuwei Song, Shariq Qayyum, Radomir Slominski, Chander Raman, Andrzej Slominski, Yuhua Song
90 [GO] 2021―Feb―12 Rationally Designed Chimeric Antibodies for COVID-19 and Future Coronavirus Variants Ching-chung Hsueh, Steven S. Plotkin
91 [GO] 2021―Feb―12 COVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels Mark Szendrey, Jun Guo, Wentao Li, Tonghua Yang, Shetuan Zhang
92 [GO] 2021―Feb―12 Investigational Treatments for COVID-19 May Increase Ventricular Arrhythmia Risk through Drug Interactions Meera Varshneya, Itziar Irurzun-Arana, Chiara Campana, Rafael Dariolli, Amy Gutierrez, Taylor K. Pullinger, Eric A. Sobie
93 [GO] 2021―Feb―12 Introductory Models of the Covid-19 Pandemic in the United States Peter H. Nelson
94 [GO] 2021―Feb―12 Identification of FDA Approved Antiviral Drugs for COVID-19 Treatment using Unbiased Virtual Screening Rory Greer, Yuwei Song, Michael J. Patton, Matthew Might, Kevin Harrod, Chad M. Petit, Yuhua Song
95 [GO] 2021―Feb―12 Coronavirus Envelope Protein: Lipid Sensitivity and Membrane Bending Jesse Sandberg, Grace H. Brannigan
96 [GO] 2021―Feb―12 Coronavirus Pathogenicity is Determined by Stability of the Spike Protein Open Conformation Josiah Bones, Ben Corry
97 [GO] 2021―Feb―12 Modeling and Manipulating Antibody Response Against Influenza and Coronavirus Spike Proteins and Exploring their Role in Directing Spike Evolution Assaf Amitai, Maya Sangesland, Daniel Lingwood, Arup K. Chakraborty
98 [GO] 2021―Feb―12 Anti-Frameshifting Ligand Active against SARS Coronavirus-2 is Resistant to Natural Mutations of the Frameshift-Stimulatory Pseudoknot Krishna Neupane, Sneha Munshi, Meng Zhao, Dustin Ritchie, Sandaru M. Ileperuma, Michael T. Woodside
99 [GO] 2021―Feb―12 Differential Dynamic Behavior of Prefusion Spike Glycoproteins of Sars Coronaviruses 1 and 2 Mahmoud Moradi, Vivek Govind Kumar, Dylan S. Ogden, Ugochi Isu, James Losey
100 [GO] 2021―Feb―12 Distinct Differences in the Interactions of Receptor Binding Domains of SARS-CoV-2 and SARS-CoV with Human ACE2 Atanu Acharya, Anna Pavlova, Christophe J. Chipot, James C. Gumbart
101 [GO] 2021―Feb―12 An Integrative MD Simulation and Network Analysis Approach to Study Glycosylation of Spike in SARS-CoV-2 Mahdi Ghorbani, Bernard R. Brooks, Jeffery B. Klauda
102 [GO] 2021―Feb―12 Combining Computational Modeling with Library Screening to Adapt SARS-CoV-Neutralizing Antibody 80R to SARS-CoV-2 Michael S. Kent, Maxwell Stefan, Kenneth Sale, Corey Hudson, Daniella Martinez, Miranda Juarros, et al. (+5)
103 [GO] 2021―Feb―12 Modeling Protein-Lipid Interactions during Viral Assembly of SARS-CoV-2 Viviana Monje-Galvan, Alexander Pak, Gregory A. Voth
104 [GO] 2021―Feb―12 Adaptive Evolution of Peptide Inhibitors for Mutating SARS-CoV-2 Parth Chaturvedi, Yanxiao Han, Petr Král, Lela Vukovic
105 [GO] 2021―Feb―12 Quantitative Fluorescence Microscopy on SARS-CoV-2 Rayna M. Addabbo, John Kohler, Isaac Angert, Yan Chen, Heather Hanson, Louis M. Mansky, Joachim D. Mueller
106 [GO] 2021―Feb―12 The Effect of Glycans Steric Potentials on Virus Infectivity- the SARS-Cov-2 Case Giuseppe Battaglia
107 [GO] 2021―Feb―12 Characterization of SARS-CoV-2 Conserved Elements’ Structures and their RNA-RNA Interactions Caylee Cunningham, Joshua Imperatore, Ella Milback, Morgan Shine, Kendy A. Pellegrene, Patrick Lackey, et al. (+2)
108 [GO] 2021―Feb―12 Structural Dynamics of SARS-CoV-2 Frameshift Signal Studied by Single-Molecule Force Spectroscopy Reveal Topologically Distinct Conformers Krishna P. Neupane, Meng Zhao, Noel Q. Hoffer, Aaron Lyons, Sneha Munshi, Dustin Ritchie, Michael T. Woodside
109 [GO] 2021―Feb―12 High-Coverage Nucleic Acid Probes for Distinguishing SARS-COV-2 from Influenza Samantha J. Courtney, Zachary R. Stromberg, James Theiler, Brian T. Foley, Jason D. Gans, Karina Yusim, Jessica Z. Kubicek-Sutherland
110 [GO] 2021―Feb―12 The Design of a Destabilizer Peptide to Disrupt SARS-CoV-2 Fusion with Its Targeted Cell Membrane Motamed Qadan
111 [GO] 2021―Feb―12 SARS-CoV-2 Glycosylated Spike Activation Mechanism - Simulations of the Full Unbiased Pathway Terra Sztain-Pedone, Surl-Hee Ahn, Anthony Bogetti, Lorenzo Casalino, Zied Gaieb, James A. McCammon, et al. (+2)
112 [GO] 2021―Feb―12 Inhibitor Binding Influences the Protonation State of Histidines in SARS-CoV-2 Main Protease Anna Pavlova, Diane L. Lynch, Micholas Dean Smith, Jeremy D. Smith, James C. Gumbart
113 [GO] 2021―Feb―12 The Effect of Point Mutations on Structure and Dynamics of SARS-CoV-2 Main Protease Mutants Elizabeth M. Diessner, Zixiao Zong, Thomas J. Cross, Gemma R. Takahashi, Marquise G. Crosby, Vesta Farahmad, et al. (+3)
114 [GO] 2021―Feb―12 Force-Dependent Stimulation of RNA Unwinding by SARS-CoV-2 NSP13 Helicase Keith J. Mickolajczyk, Patrick M. Shelton, Michael Grasso, Xiaocong Cao, Sara E. Warrington, Amol Aher, et al. (+2)
115 [GO] 2021―Feb―12 DNA Folding by the SARS-CoV-2 Nucleocapsid Protein Youna N. Choi, Ryan B. McMillan, Ashley R. Carter
116 [GO] 2021―Feb―12 Investigating SARS-CoV-2 Orf7B Homodimerization by Molecular Dynamics Simulations Min-Kang Hsieh, Jeffery B. Klauda
117 [GO] 2021―Feb―12 Dynamics and Binding Strength of the Spike Protein of Sars-Cov-2 Probed by High-Speed Atomic Force Microscopy Fidan Sumbul, Claire Valotteau, Ignacio Fernandez, Analisa Meola, Eduard Baquero, Dorota Kostrz, et al. (+4)
118 [GO] 2021―Feb―12 Automated Computational Technique to Improve the Quality of SARS-CoV-2 Proteins Joseph P. Farrell, Esmael J. Haddadian
119 [GO] 2021―Feb―12 Using Tactics to Find Druggable Pockets in SARS-CoV-2 Proteins Daniel J. Evans, Remy A. Yovanno, Sanim Rahman, Afif Bandak, Albert Y. Lau
120 [GO] 2021―Feb―12 Prediction and Analysis of Multiple Sites and Inhibitors of SARS-CoV-2 Proteins Suhasini M. Iyengar, Kelton Barnsley, Hoang Yen Vu, Ryan Dilworth, Jana Sefcikova, Penny Beuning, Mary Jo Ondrechen
121 [GO] 2021―Feb―12 Characterizing Binding Kinetics and Thermodynamics of Computer-Designed Nanobodies Targeting SARS-CoV-2 RBD Matheus Ferraz, Roberto Lins
122 [GO] 2021―Feb―12 Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2 Kien Nguyen, Srirupa Chakraborty, Rachael A. Mansbach, Pedro D. Manrique, Bette Korber, Sandrasegaram Gnanakaran
123 [GO] 2021―Feb―12 The Effect of Mutations on Binding Interactions Between the SARS-CoV-2 Receptor Binding Domain and Neutralizing Antibodies Jonathan E. Barnes, Peik K. Lund-Andersen, Jagdish S. Patel, F. Marty Ytreberg
124 [GO] 2021―Feb―12 Modeling the Structure of the Frameshift-Stimulatory Pseudoknot in SARS-CoV-2 Reveals Multiple Possible Conformers Sara Ibrahim Omar, Meng Zhao, Rohith Vedhthaanth Sekar, Sahar Arbabimoghadam, Jack A. Tuszynski, Michael T. Woodside
125 [GO] 2021―Feb―12 Energetics of Opening for the Glycosylated and Unglycosylated Forms of the SARS-CoV-2 S-Protein Trimer Yui Tik Pang, Atanu Acharya, Diane L. Lynch, James C. Gumbart
126 [GO] 2021―Feb―12 Enhanced Sampling of the SARS-CoV-2 s2m Element Adam H. Kensinger, Kendy A. Pellegrene, Joshua Imperatore, Matthew N. Srnec, Mihaela-Rita Mihailescu, Jeffrey D. Evanseck
127 [GO] 2021―Feb―12 Condensed Liquid Phase 3D Structure of SARS-CoV-2 s2m Guided by NMR Spectroscopy Kendy A. Pellegrene, Joshua A. Imperatore, Caylee L. Cunningham, Adam H. Kensinger, Petru Mihailescu, Matthew N. Srnec, et al. (+2)
128 [GO] 2021―Feb―12 SARS-CoV-2 Simulations go Exascale to Capture Spike Opening and Reveal Cryptic Pockets Across the Proteome Maxwell I. Zimmerman, Gregory Bowman
129 [GO] 2021―Feb―12 Essential Dynamics that Drive Sars-Cov-2 Spike Conformational Changes Srirupa Chakraborty, Rachael A. Mansbach, Kien Nguyen, Pedro D. Manrique, Sandrasegaram Gnanakaran
130 [GO] 2021―Feb―12 Identifying Hotspots in Binding of SARS-CoV-2 Spike Glycoprotein and Human ACE2 Jenny Mendis, Ekrem Kaya, Tugba G. Kucukkal
131 [GO] 2021―Feb―12 Inhibition of SARS-CoV-2 Spike Protein Function by Amphiphilic Block Copolymers Michelle X. Ling, Michelle Nguyen, Kyle McCollum, Raphael C. Lee
132 [GO] 2021―Feb―12 Refinement of the Transmembrane Domain in Constructing the Membrane-Embedded SARS-COV-2 Spike Protein Model Tianle Chen, Karan Kapoor, Emad Tajkhorshid
133 [GO] 2021―Feb―12 The Influence of Glycosylation on the Interaction of the Sars-Cov-2 Spike Protein Receptor Binding Domain with Therapeutic Candidates. Bradley Harris, Yihan Huang, Giovanni Lara, Shiaki Minami, Matthew Kenaston, Seongwon Jung, et al. (+5)
134 [GO] 2021―Feb―12 The Extended Intermediate of the SARS-CoV-2 Spike Protein uses Extreme Reach and Flexibility to Capture Host Cell Membranes Rui Su, Jin Zeng, Sathish Thiyagarajan, Ben O'Shaughnessy
135 [GO] 2021―Feb―12 Mapping Binding Interfaces and Allosteric Changes in the SARS-Cov-2 Spike Protein using Hydrogen/Deuterium Exchange Mass Spectrometry Shawn M. Costello, Helen T. Hobbs, Sophie R. Shoemaker, Abigail E. Powell, Shion A. Lim, James A. Wells, et al. (+3)
136 [GO] 2021―Feb―12 The SARS-CoV-2 Spike Variant D614G Favors an Open Conformational State Rachael A. Mansbach, Srirupa Chakraborty, Kien Nguyen, David C. Montefiori, Bette Korber, Gnana Gnanakaran
137 [GO] 2021―Feb―12 Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles Maolin Lu, Pradeep D. Uchil, Wenwei Li, Daniel S. Terry, Jason Gorman, Baoshang Zhang, et al. (+9)
138 [GO] 2021―Feb―12 Predicting the Ability of SARS-CoV-2 to Utilize the ACE2 Receptor for Cell Entry in North American Rodents Peik K. Lund-Andersen, Jeremy R. Ellis, James T. Van Leuven, Jagdish Patel
139 [GO] 2021―Feb―12 Understanding Activation and Inhibition of SARS-CoV-2 Viral Entry with Single-Virus Microscopy Anjali Sengar, Giorgio Morbioli, Peter Kasson
140 [GO] 2021―Feb―12 Topography, Spike Dynamics and Nanomechanics of Individual Native SARS-CoV-2 Virions Balint Kiss, Zoltán Kis, Bernadett Pályi, Miklós S. Kellermayer
141 [GO] 2021―Feb―12 Adaptive Evolution of SARS-CoV-2: A Perspective from Dynamics Ismail C. Kazan, S. Banu Ozkan
142 [GO] 2021―Feb―12 Conserved Elements in the 3'-UTR of SARS-CoV-2: Involvement in Genomic Dimerization and Interactions with Cellular Micrornas Joshua A. Imperatore, Caylee L. Cunningham, Caleb J. Frye, Kendy A. Pellegrene, Jeffrey D. Evanseck, Mihaela-Rita Mihailescu
143 [GO] 2021―Feb―12 Mechanism and Pathways of Inhibitor Binding to the Human ACE2 Receptor for SARS-CoV1/2 Apurba Bhattarai, Shristi Pawnikar, Yinglong Miao
144 [GO] 2021―Feb―12 Factors that Affect the Binding of the N-Terminal Helix of Human ACE2 to Spike Protein of SARS-CoV2 Anirban Das, Vicky Vishvakarma, Ankur Gupta, Simli Dey, Arpan Dey, U. Sandra, et al. (+5)
145 [GO] 2021―Feb―12 Elucidating the Mechanism of Membrane Destabilization by the Preferred Modes of Insertion of the Sars-Cov2 Fusion Peptide George Khelashvili, Harel Weinstein
146 [GO] 2021―Feb―12 Binding Mode of SARS-CoV2 Fusion Peptide to Human Cellular Membranes Defne Gorgun, Muyun Lihan, Karan Kapoor, Emad Tajkhorshid
147 [GO] 2021―Feb―12 Hepatitis C Virus Protease Inhibitors Suppress Virus Replication and Act Synergistically with the SARS-CoV2 Polymerase Inhibitor Remdesivir Khushboo Bafna, Kris White, Balasubramanian Harish, Catherine A. Royer, Adolfo Garcia-Sastre, Robert M. Krug, Gaetano T. Montelione
148 [GO] 2021―Feb―03 Bow to the Enemy: How Flexibility of Host Protein Receptors Can Favor SARS-CoV-2 Stefano A. Serapian, Giorgio Colombo
149 [GO] 2021―Feb―03 Graph, Pseudoknot, and SARS-Cov-2 Genomic RNA - a Biophysical Synthesis Shi-Jie Chen
150 [GO] 2021―Jan―26 A Multiscale Coarse-grained Model of the SARS-CoV-2 Virion John E. Straub
151 [GO] 2021―Jan―21 Elucidation of Interactions Regulating Conformational Stability and Dynamics of SARS-CoV-2 S-Protein Takaharu Mori, Jaewoon Jung, Chigusa Kobayashi, Hisham M. Dokainish, Suyong Re, Yuji Sugita
152 [GO] 2021―Jan―17 Improving SARS-CoV-2 Structures: Peer Review by Early Coordinate Release Tristan I. Croll, Christopher J. Williams, Vincent B. Chen, David C. Richardson, Jane S. Richardson
153 [GO] 2020―Dec―25 The molecular mechanism of domain-swapping of the C-terminal domain of the SARS coronavirus main protease Vishram L. Terse, Shachi Gosavi
154 [GO] 2020―Dec―17 Force-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase Keith J. Mickolajczyk, Patrick M.M. Shelton, Michael Grasso, Xiaocong Cao, Sara E. Warrington, Amol Aher, et al. (+2)
155 [GO] 2020―Nov―28 Thermal Inactivation Scaling Applied for SARS-CoV-2 Shahar Seifer, Michael Elbaum
156 [GO] 2020―Nov―28 A Multiscale Coarse-grained Model of the SARS-CoV-2 Virion Alvin Yu, Alexander J. Pak, Peng He, Viviana Monje-Galvan, Lorenzo Casalino, Zied Gaieb, et al. (+3)
157 [GO] 2020―Nov―13 The flexibility of ACE2 in the context of SARS-CoV-2 infection Emilia P. Barros, Lorenzo Casalino, Zied Gaieb, Abigail C. Dommer, Yuzhang Wang, Lucy Fallon, et al. (+4)
158 [GO] 2020―Oct―21 Structure-Altering Mutations of the SARS-CoV-2 Frame Shifting RNA Element Tamar Schlick, Qiyao Zhu, Swati Jain, Shuting Yan
159 [GO] 2020―Aug―08 Reflections on the Pandemic H. Jane Dyson
 [1] 

159 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.011 sec